Exosome Hair Therapy in London

In short

Exosome hair therapy is a scalp treatment in which a preparation of extracellular vesicles is applied after microneedling, so that material passes through a temporarily breached skin barrier into living tissue. It is offered widely across London, usually as a course of three sessions with proposed maintenance afterwards.

The point most London marketing skips is regulatory. No exosome product holds a UK marketing authorisation for treating hair loss, injection is not a licensed route for any of them, and the published evidence in androgenetic alopecia is early. Two treatments with regulatory approval and decades of clinical data exist for the same condition. A clinic that discusses those first is telling you something useful about itself.

What the treatment actually involves

A scalp appointment in a London clinic follows a fairly consistent shape wherever it is offered. The scalp is cleaned, sometimes with topical anaesthetic applied first. A microneedling device passes over the treatment area to a set depth, creating thousands of small channels. A liquid preparation described as exosomes is then applied to the treated surface, and is often massaged in or left in place for a period afterwards. Some clinics use a further pass at a shallower depth to work the material in.

The mechanical part of that sequence is not in dispute. Microneedling on the scalp creates controlled injury, provokes a wound healing response, and improves the passage of applied material through a barrier that would otherwise exclude particles of this size entirely. Our main guide sets out why the route of administration matters more in this treatment than in almost any other.

What is in dispute is the contribution of the preparation itself. Because the needling alone produces an effect on the scalp, and because almost every clinical protocol combines the two, separating what the vesicles contributed from what the needling contributed is genuinely difficult. That attribution problem runs through the whole category and it is the reason candour about the evidence is worth more than enthusiasm about the mechanism.

Where UK regulation stands

This is the part to establish before anything else, because it does not vary by clinic or by borough. No exosome preparation currently holds a UK marketing authorisation as a medicine for hair loss. That means no regulator has assessed a specific product for quality, safety and efficacy in this use and concluded that it should be licensed for it.

Injection is not a licensed route for any exosome product in the UK, which is why the microneedling and topical application route is the one used in practice. Products in this space are supplied under a variety of descriptions, and how a particular preparation is classified depends on what it contains and how it is presented, which is precisely why the classification question is worth asking directly. The current position should be checked with the Medicines and Healthcare products Regulatory Agency rather than taken from a clinic website, including this one. Our regulation page covers the overlapping frameworks in detail.

Two consequences follow and both affect you directly. There is no defined product recall route for something that is not a licensed medicine, and there is no dossier a regulator can point you to if you want to know what is in the vial. What you still have is the professional regulator that governs the practitioner, which is why the register check matters more here than in a treatment with a licence behind it.

How it compares with the licensed options

Androgenetic alopecia is one of the few conditions in aesthetic medicine with well established treatments behind it. Topical minoxidil and oral finasteride have regulatory approval and decades of clinical data, and both act on the mechanism that drives the condition rather than on the general health of the scalp. Neither is glamorous and neither is sold at a London consultation price.

That does not make exosome treatment unreasonable. It makes the sequence unreasonable when it is reversed. Choosing an unlicensed option before trying a licensed one is a decision you are entitled to make, but it should be a decision rather than an omission, and a consultation that never mentions the licensed class has omitted the part that matters. Platelet rich plasma sits between the two, with a longer clinical history in this indication than exosome preparations and a different practical profile.

Our hair loss page sets each of these against the others by mechanism, regulatory status and evidence quality, and it does not conclude that any one of them wins.

What the evidence actually supports

The published work on extracellular vesicles in hair loss is early. Studies tend to be small, follow up tends to be short, outcome measures vary between papers, and the preparations used are not equivalent to one another, which makes pooling results across studies difficult even where the results are positive.

None of that means the biology is empty. It means a patient being offered this treatment is contributing to an evidence base rather than benefiting from an established one, and is entitled to be told so plainly. Our evidence page grades the quality of the literature qualitatively rather than reducing it to a number, because reducing it to a number would create a precision that the underlying studies do not support.

The realistic framing for a London patient is this. If the treatment works, it works gradually, partially, and in combination with a healing response you would have got from the needling anyway. It does not restore hair to a scalp where the follicles have gone. It is not a transplant and it does not substitute for one.

What is specific to London

London has the densest concentration of clinics offering this treatment anywhere in the UK, which is useful for choice and unhelpful for comparison. Prices span a wider range than the treatment itself does, the same protocol appears under several different names, and the standard of the regulatory conversation varies enormously between practices that are physically ten minutes apart.

The practical consequence is that the differentiator is the consultation rather than the technology. Clinics working in regenerative aesthetics that describe these preparations accurately are more useful to a reader than those that do not, and London practices operating in this area, among them Mesglo London, tend to present the category as emerging rather than established. That framing is the minimum a patient should expect wherever the treatment is offered, and its absence is the clearest signal available to someone comparing clinics. We assess nobody's results and we recommend no practice.

Whichever clinic you approach, check the practitioner directly. Doctors appear on the General Medical Council register and nurses on the Nursing and Midwifery Council register. Both checks take under a minute.

What it costs in London in 2026

These are indicative ranges observed across the UK market rather than quotations, and London sits at or above the top of each. A single scalp session commonly falls between about £300 and £700. A course of three, which is the most commonly sold package, commonly falls between about £850 and £1,800. Courses of six, sold where response is described as gradual, commonly fall between about £1,500 and £3,200. Maintenance sessions are commonly quoted between about £200 and £600 at intervals that vary widely between clinics.

The comparison worth making before you commit is against microneedling alone, commonly between about £150 and £350 a session, and against a year of topical minoxidil, commonly between about £60 and £200. The difference between the needling price and the protocol price is what the preparation is actually costing you, and it is the only number in the conversation that isolates the ingredient under discussion. Our cost page lays that comparison out in full.

What to ask before booking

Four questions do most of the work, and none of them requires any technical knowledge to ask.

What exactly is in the preparation, what is its source, and how is it classified for use in the UK. What is your evidence for using it in androgenetic alopecia specifically, rather than in skin. Have we discussed the licensed treatments for this condition and, if we have ruled them out, why. And what will you do if there is no change after the course, including whether further sessions would be charged.

A practitioner who answers those four plainly, including the parts that are unflattering to the treatment, is a practitioner worth continuing with. One who treats the regulatory question as an irrelevance has told you what you needed to know. The twelve consultation questions on this site expand the same approach into a printable list.

Common questions

Is exosome hair therapy licensed in the UK?

No exosome product holds a UK marketing authorisation as a medicine for hair loss, and injection is not a licensed route for any of them, which is why the treatment is delivered by application after microneedling. How a particular preparation is classified depends on what it contains and how it is presented. The current position should be checked with the MHRA rather than taken from any clinic website.

How does it compare with minoxidil and finasteride?

Topical minoxidil and oral finasteride have regulatory approval and decades of clinical data in androgenetic alopecia, and they act on the mechanism driving the condition. Exosome preparations do not have that evidence base or that regulatory status. Choosing the unlicensed option first is a decision you are entitled to make, but a consultation that never mentions the licensed class has left out the most important comparison.

How many sessions are needed and how soon would anything show?

A course of three sessions is the most commonly sold package, often with maintenance proposed afterwards. Any change follows the slow timescale of the healing response rather than the treatment itself, so assessment belongs at three to six months. Redness and shedding in the first week are the needling, not the result.

Will it work if I am already bald in an area?

No. These treatments are proposed to influence follicles that are still present but miniaturising. Where a follicle has gone, nothing applied to the surface of the scalp brings it back, and the options at that point are surgical rather than topical. A clinic that does not make that distinction during the examination has not examined you properly.

Why do London prices vary so much for the same treatment?

Because the preparation, the number of passes, the depth used, the seniority of the person treating you and the overheads of the premises all vary, and none of them is disclosed in a price list. The useful comparison is the gap between the clinic's price for microneedling alone and its price for the protocol, because that gap is what the preparation is costing you.

Sources

Disclosure

Exosomes Therapy is published by Northbank Media. This article carries one link to an external business. That link was placed for editorial reasons by the publisher, it was not sold, exchanged or paid for in any form, and the business concerned had no sight of this article before publication and no right of approval over it. Northbank Media does not sell links, placements, reviews or coverage on any of its titles. The full position is set out in our editorial policy.

If you want to speak to someone

We are not a clinic and we give no medical advice. If you would like to, we can pass your details to a registered UK practitioner who will contact you directly. Nothing is booked on your behalf and there is no obligation. Read the regulation page first.

Make an enquiry

Exosome hair therapy in London: the complete guide